Chemical Compound

L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-; L-threo-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-(methylsulfinyl)-, trans-a- (8CI); L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-(methylsulfinyl)-, [2S-(2a,4ss)]-; 7-Chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-a-D-galacto-octopyranose; 7(S)Chloro-7-deoxylincomycin sulfoxide; Clindamycin sulfoxide; U 25026A; Mixture of clindamycin sulfoxide isomers 1 & 2

CAS Registry Number 22431-46-5
L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-; L-threo-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-(methylsulfinyl)-, trans-a- (8CI); L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-(methylsulfinyl)-, [2S-(2a,4ss)]-; 7-Chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-a-D-galacto-octopyranose; 7(S)Chloro-7-deoxylincomycin sulfoxide; Clindamycin sulfoxide; U 25026A; Mixture of clindamycin sulfoxide isomers 1 & 2 结构式
Primary record

L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-; L-threo-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-(methylsulfinyl)-, trans-a- (8CI); L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-(methylsulfinyl)-, [2S-(2a,4ss)]-; 7-Chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-a-D-galacto-octopyranose; 7(S)Chloro-7-deoxylincomycin sulfoxide; Clindamycin sulfoxide; U 25026A; Mixture of clindamycin sulfoxide isomers 1 & 2

库存
1,479 克
纯度
99.2 %
CAS
22431-46-5

化合物标识与属性

CAS
22431-46-5
PubChem CID
11662169
SMILES
CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)S(=O)C)O)O)O)[C@H](C)Cl
Canonical SMILES
CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](S(C)=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1

名称与同义词

  • Clindamycin Sulfoxide
  • clindamycinsulfoxid
  • AM87UQ20EB
  • Clindamycin Impurity 8
  • UNII-AM87UQ20EB
  • RefChem:126974
  • (Mixture of Diastereomers)
  • 22431-46-5
  • Clindamycin Sulfoxide Impurity
  • orb1694361
  • 7(S)Chloro-7-deoxylincomycin sulfoxide
  • Clindamycin Phosphas Impurity 44
  • U 25026A
  • AKOS040754787
  • CS-O-05845
  • CID11662169
  • CID 11662169
  • Clindamycin Sulfoxide(Mixture of Diastereomers)
  • HY-127059
  • CS-0092523
  • 7-CHLORO-1,6,7,8-TETRADEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-(METHYLSULFINYL)-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSE
  • 7-Chloro-1,6,7,8-tetradeoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-(methylsulfinyl)-L-threo-alpha-D-galacto-octopyranose
  • L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSE, 7-CHLORO-1,6,7,8-TETRADEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-(METHYLSULFINYL)-
  • L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSE, 7-CHLORO-1,6,7,8-TETRADEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-(METHYLSULFINYL)-, (2S-(2.ALPHA.,4.BETA.))-
  • L-Threo-alpha-D-galacto-octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-(methylsulfinyl)-
  • L-Threo-alpha-D-galacto-octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-(methylsulfinyl)-, (2S-(2alpha,4beta))-
  • (2R)-N-[2-chloro-1-[(3R,4R,6R)-3,4,5-trihydroxy-6-methylsulfinyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
  • (2R,4S)-N-((1S,2S)-2-Chloro-1-((2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-((S)-methanesulfinyl)oxan-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboximidate
  • (2R,4S)-N-((1S,2S)-2-Chloro-1-((2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-((S)-methanesulphinyl)oxan-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboximidate
  • (2R,4S)-N-((1S,2S)-2-Chloro-1-((2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-((S)-methanesulphinyl)oxan-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboximidic acid
  • (2R,4S)-N-[(1S,2S)-2-Chloro-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[(S)-methanesulfinyl]oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidate
  • (2R,4S)-N-[(1S,2S)-2-Chloro-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[(S)-methanesulphinyl]oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidate
  • (2R,4S)-N-[(1S,2S)-2-Chloro-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[(S)-methanesulphinyl]oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid
  • (2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfinyl)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
  • 7-Chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-alpha-D-galactooctopyranose
  • L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-; L-threo-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-(methylsulfinyl)-, trans-a- (8CI); L-threo-a-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-(methylsulfinyl)-, [2S-(2a,4ss)]-; 7-Chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-a-D-galacto-octopyranose; 7(S)Chloro-7-deoxylincomycin sulfoxide; Clindamycin sulfoxide; U 25026A; Mixture of clindamycin sulfoxide isomers 1 & 2